Trial NCT02115386

View at ClinicalTrials.gov 
Org. Study IDs: CAMN107ARU02

Last trial update was posted on 2019-12-10

MeSH Interventions

Nilotinib

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid

Other Conditions

Philadelphia Positive (Ph+) Chronic Myeloid Leukemia

Stopping Reasons

Study was terminated by Novartis

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID